• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE Back to Search Results
Model Number ESS305
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Memory Loss/Impairment (1958); Pain (1994); Visual Impairment (2138); Burning Sensation (2146); No Code Available (3191)
Event Date 03/01/2019
Event Type  Injury  
Event Description
This case was initially received via regulatory authority ((b)(6), reference number: (b)(4)) on 25-feb-2020.This spontaneous case was reported by a consumer and describes the occurrence of renal pain ('kidney pain') in a (b)(6) year old female patient who had essure (batch no.772497) inserted.The occurrence of additional non-serious events is detailed below.On an unknown date, the patient had essure inserted.On (b)(6) 2019, the patient experienced renal pain (seriousness criterion medically significant), vulvovaginal burning sensation ("vaginal burning"), visual impairment ("vision disorder") and memory impairment ("memory disorder").At the time of the report, the renal pain, vulvovaginal burning sensation, visual impairment and memory impairment outcome was unknown.The reporter considered memory impairment, renal pain, visual impairment and vulvovaginal burning sensation to be related to essure.We received a lot number in this case.A technical investigation will be conducted, including a batch review, and a review of complaint records and other relevant data; should any new and reportable information become available from our investigation, this will be provided in a supplementary report.
 
Manufacturer Narrative
This case was initially received via regulatory authority (ansm, reference number: (b)(4)) on (b)(6) 2020.The most recent information was received on 23-mar-2020.This spontaneous case was reported by a consumer and describes the occurrence of medical device removal ('medical device removal') and renal pain ('kidney pain') in a 52-year-old female patient who had essure (batch no.772497) inserted.The occurrence of additional non-serious events is detailed below.On an unknown date, the patient had essure inserted.On (b)(6) 2019, the patient experienced renal pain (seriousness criterion medically significant), vulvovaginal burning sensation ("vaginal burning"), visual impairment ("vision disorder") and memory impairment ("memory disorder").On an unknown date, the patient underwent medical device removal (seriousness criteria medically significant and intervention required) and experienced tendonitis ("tendonitis").The patient was treated with surgery (essure removal).Essure was removed on (b)(6) 2011.At the time of the report, the medical device removal, renal pain, vulvovaginal burning sensation, visual impairment, memory impairment and tendonitis outcome was unknown.The reporter provided no causality assessment for tendonitis with essure.The reporter considered medical device removal, memory impairment, renal pain, visual impairment and vulvovaginal burning sensation to be related to essure.The reporter commented: date of onset: (b)(6) 2011 and period of onset: 3 weeks after insertion.The consumer stated she was badly affected because of all of the problems caused by this implant.Lot number: 772497, manufacturing date: 2010-08, expiration date: 2013-08.Quality-safety evaluation of ptc: unable to confirm complaint.Most recent follow-up information incorporated above includes: on 23-mar-2020: essure removal date provided.Events tendonitis and medical device removal added.The event kidney pain was updated to non-serious incident.We received a lot number in this case.A technical investigation was conducted, including a batch review, and a review of complaint records and other relevant data; should any new and reportable information become available from our investigation, this will be provided in a supplementary report.
 
Manufacturer Narrative
This case was initially received via regulatory authority (ansm, reference number: (b)(4)) on (b)(6) 2020.The most recent information was received on 11-mar-2020.This spontaneous case was reported by a consumer and describes the occurrence of renal pain ('kidney pain') in a 52-year-old female patient who had essure (batch no.772497) inserted.The occurrence of additional non-serious events is detailed below.On an unknown date, the patient had essure inserted.On (b)(6) 2019, the patient experienced renal pain (seriousness criterion medically significant), vulvovaginal burning sensation ("vaginal burning"), visual impairment ("vision disorder") and memory impairment ("memory disorder").At the time of the report, the renal pain, vulvovaginal burning sensation, visual impairment and memory impairment outcome was unknown.The reporter considered memory impairment, renal pain, visual impairment and vulvovaginal burning sensation to be related to essure.Lot number: 772497, manufacturing date: 2010-08, expiration date: 2013-08.Quality-safety evaluation of ptc: unable to confirm complaint.Most recent follow-up information incorporated above includes: on 11-mar-2020: quality safety evaluation of ptc.We received a lot number in this case.A technical investigation will be conducted, including a batch review, and a review of complaint records and other relevant data; should any new and reportable information become available from our investigation, this will be provided in a supplementary report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
MDR Report Key9758904
MDR Text Key187685260
Report Number2951250-2020-01741
Device Sequence Number1
Product Code HHS
UDI-Device Identifier10888853003051
UDI-Public(01)10888853003051
Combination Product (y/n)N
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign,other
Type of Report Initial,Followup,Followup
Report Date 03/27/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/01/2013
Device Model NumberESS305
Device Lot Number772497
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/25/2020
Initial Date FDA Received02/26/2020
Supplement Dates Manufacturer Received02/25/2020
03/11/2020
Supplement Dates FDA Received03/12/2020
03/27/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age52 YR
-
-